Amgen says FTC has ignored commitments it made to address Horizon deal concerns
Amgen (AMGN) CEO Robert Bradway said the Federal Trade Commission has ignored the commitments that the company has made to address concerns over its deal to acquire Horizon.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.